Cargando…
The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with tumorigenesis. However, the relationship between cuproptosis and patient prognosis in clear cell renal cell carcinoma (cc...
Autores principales: | Zhang, Lishuo, Di, Longjiang, Liu, Jinhui, Lei, Xianli, Gu, Maoli, Zhang, Wenjing, Wang, Yufu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899836/ https://www.ncbi.nlm.nih.gov/pubmed/36755568 http://dx.doi.org/10.3389/fgene.2023.1039813 |
Ejemplares similares
-
Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022) -
Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022) -
Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022) -
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023) -
Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)